Malignant Tumors: The segment of malignant tumors holds a significant share in the Gamma Knife market. Increasing cases of brain tumors and the effectiveness of Gamma Knife technology in treating these tumors are the primary factors driving the growth of this segment. The precision and control offered by Gamma Knife in targeting cancerous cells make it a preferred choice for treating malignant tumors.
Benign Tumors: Benign tumors are another crucial indication segment in the Gamma Knife market. The non-invasive nature of Gamma Knife surgery and its ability to precisely target and destroy benign tumors without damaging surrounding healthy tissue contribute to the increasing adoption of this technology for treating such conditions. The growing awareness about the benefits of Gamma Knife in treating benign tumors is expected to fuel the growth of this segment.
Vascular Disorders: Vascular disorders, such as arteriovenous malformations (AVMs) and cavernous malformations, represent a significant indication segment for Gamma Knife procedures. The ability of Gamma Knife to deliver targeted radiation therapy to abnormal blood vessels and reduce the risk of bleeding or neurological symptoms makes it a promising treatment option for patients with vascular disorders. The rising prevalence of cerebrovascular diseases is driving the demand for Gamma Knife procedures in treating vascular disorders.
Functional Disorders: The segment of functional disorders, including trigeminal neuralgia and essential tremor, is witnessing a steady growth in the Gamma Knife market. Gamma Knife radiosurgery offers a minimally invasive treatment option for patients suffering from these neurological conditions, providing long-term relief from symptoms with low risks of complications. The increasing acceptance of Gamma Knife technology for treating functional disorders is expected to propel the growth of this segment.
Ocular Diseases: Ocular diseases, such as uveal melanoma and choroidal metastases, are emerging as potential indications for Gamma Knife procedures. The ability of Gamma Knife to precisely target ocular tumors and spare critical structures in the eye makes it a promising treatment modality for patients with these conditions. The advancements in Gamma Knife technology and the expanding applications in ophthalmology are driving the adoption of Gamma Knife procedures for treating ocular diseases.